← FDA DRUG APPROVALS

FDA ANDA · ANDA075765

CALCITRIOL

Sponsor: TEVA

APPLICATION
ANDA075765
TYPE
ANDA
ORIGINAL APPROVAL
2001-10-12
LATEST ACTION
2008-07-24
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription

Products

CALCITRIOLPrescription
CALCITRIOL 0.5MCG · CAPSULE · ORAL
CALCITRIOLPrescription
CALCITRIOL 0.25MCG · CAPSULE · ORAL

Approval history

2008-07-24Labeling · Supplement 4AP
2007-02-21Labeling · Supplement 3AP
2002-09-18Labeling · Supplement 2AP
2002-04-16Manufacturing (CMC) · Supplement 1AP
2001-10-12OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →